Value of Traditional Chinese Medicine syndrome differentiation in predicting the survival time of patients with advanced cancer

J Tradit Chin Med. 2021 Aug;41(4):636-641. doi: 10.19852/j.cnki.jtcm.20210310.001.

Abstract

Objective: To prospectively study the accuracy of the palliative prognostic index (PPI) survival prediction model combined with Traditional Chinese Medicine (TCM) syndrome differentiation.

Methods: The PPI survival prediction model was used to predict survival time. Patients' real survival time was recorded. The survival time was calculated using the Kaplan-Meier method, and the logrank method was used to test the difference.

Results: The average PPI survival prediction score of 227 patients was 5.83 (95% CI: 5.29-6.37). There was a significant difference in the real-life period between the different PPI groups (P < 0.05). PPI group I (predicted survival of > 6 weeks) showed the highest predictive sensitivity and PPI group II (predicted survival of 3-6 weeks) showed the highest predictive specificity. According to TCM syndrome differentiation, 82 cases (36% ) were diagnosed with liver and kidney Yin deficiency (type IV). The actual survival time of type IV patients was significantly shorter than that of other types of patients (mean: 21.85 vs 28.70, P = 0.007). In group I, the median survival time of type IV patients and other types was 25 and 34 d, respectively (P < 0.001). The sensitivity and specificity of PPI prediction were improved in group II by TCM syndrome differentiation. For patients in group III whose predicted survival time was < 3 weeks, the specificity of PPI survival prediction was higher in type IV patients.

Conclusion: This study shows that the PPI predictive tool for survival rate has important value. TCM syndrome differentiation and typing has certain significance for further classification and survival prediction.

Keywords: Palliative care; Prognosi; Survival; Syndrome complex; Yin deficiency.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Medicine, Chinese Traditional*
  • Neoplasms* / drug therapy
  • Palliative Care
  • Prognosis
  • Sensitivity and Specificity